SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-14-004010
Filing Date
2014-12-02
Accepted
2014-12-02 08:00:46
Documents
4
Period of Report
2014-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8k.htm 8-K 37617
2 EXHIBIT 2.1 ex2-1.htm EX-2.1 497118
3 EXHIBIT 99.1 ex99-1.htm EX-99.1 15791
4 GRAPHIC logo1.jpg GRAPHIC 4706
  Complete submission text file 0001493152-14-004010.txt   558549
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 141259262
SIC: 2834 Pharmaceutical Preparations